Roy S. Herbst, M.D., Ph.D.
DirectoratImmunocore Holdings· In proxies 2023–2025
Roy S. Herbst, M.D., Ph.D. sits on 2 public boards.
Boards1
- Immunocore HoldingsDirector · 4 yr on the boardIndependent—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Immunocore HoldingsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -42%
- Shanghai Junshi Biosciences Co.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?